Behr MA - Search Results

1

Tran V, Liu J, Behr MA. Tran V, et al. Among authors: behr ma. Microbiol Spectr. 2014 Feb;2(1):MGM2-0028-2013. doi: 10.1128/microbiolspec.MGM2-0028-2013. Microbiol Spectr. 2014. PMID: 26082111 Free article. Review.

2

Comparative genomics of BCG vaccines by whole-genome DNA microarray.

Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM. Behr MA, et al. Science. 1999 May 28;284(5419):1520-3. doi: 10.1126/science.284.5419.1520. Science. 1999. PMID: 10348738

3

A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927.

Behr MA, Schroeder BG, Brinkman JN, Slayden RA, Barry CE 3rd. Behr MA, et al. J Bacteriol. 2000 Jun;182(12):3394-9. doi: 10.1128/JB.182.12.3394-3399.2000. J Bacteriol. 2000. PMID: 10852869 Free PMC article.

4

Correlation between BCG genomics and protective efficacy.

Behr MA. Behr MA. Scand J Infect Dis. 2001;33(4):249-52. doi: 10.1080/003655401300077180. Scand J Infect Dis. 2001. PMID: 11345214 Review.

5

Comparative genomics of BCG vaccines.

Behr MA. Behr MA. Tuberculosis (Edinb). 2001;81(1-2):165-8. doi: 10.1054/tube.2000.0253. Tuberculosis (Edinb). 2001. PMID: 11463238 Review.

6

BCG--different strains, different vaccines?

Behr MA. Behr MA. Lancet Infect Dis. 2002 Feb;2(2):86-92. doi: 10.1016/s1473-3099(02)00182-2. Lancet Infect Dis. 2002. PMID: 11901655 Review.

7

Comparative genomics in the fight against tuberculosis: diagnostics, epidemiology, and BCG vaccination.

Mostowy S, Behr MA. Mostowy S, et al. Among authors: behr ma. Am J Pharmacogenomics. 2002;2(3):189-96. doi: 10.2165/00129785-200202030-00004. Am J Pharmacogenomics. 2002. PMID: 12383025 Review.

8

Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism.

Chen JM, Alexander DC, Behr MA, Liu J. Chen JM, et al. Among authors: behr ma. Infect Immun. 2003 Feb;71(2):708-16. doi: 10.1128/IAI.71.2.708-716.2003. Infect Immun. 2003. PMID: 12540549 Free PMC article.

9

The in vitro evolution of BCG vaccines.

Mostowy S, Tsolaki AG, Small PM, Behr MA. Mostowy S, et al. Among authors: behr ma. Vaccine. 2003 Oct 1;21(27-30):4270-4. doi: 10.1016/s0264-410x(03)00484-5. Vaccine. 2003. PMID: 14505909

10

Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.

Belley A, Alexander D, Di Pietrantonio T, Girard M, Jones J, Schurr E, Liu J, Sherman DR, Behr MA. Belley A, et al. Among authors: behr ma. Infect Immun. 2004 May;72(5):2803-9. doi: 10.1128/IAI.72.5.2803-2809.2004. Infect Immun. 2004. PMID: 15102790 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page